Processa Pharmaceuticals grants 8,450 RSUs to executive
Processa Pharmaceuticals, Inc. officer Patrick Lin received a grant of 8,450 Restricted Stock Units on 2026-07-26.
Rhea-AI Filing Summary
Processa Pharmaceuticals, Inc. officer Patrick Lin received a grant of 8,450 Restricted Stock Units on 2026-07-26. Each RSU equals one share of common stock, vesting upon grant but distributed only at the earlier of termination, six months after grant, a change of control, or death. Following this award, he holds 11,389 RSUs, stock options over 8,160 shares at an exercise price of $4.9600 that vest over three years, and common stock holdings of 13,113 shares directly plus 1,740 shares indirectly through the Lin Family Trust. These amounts reflect a 1-for-25 reverse stock split effective December 17, 2025, and were not reported as made under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 8,450 shares
Grant/Award
4 txns
Insider
Lin Patrick
Role
Chief Business - Strategy Off
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units F1, F3 | 8,450 | $0.00 | $0.00 |
| holding | Stock Options (Right to Buy) F2, F3 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 11,389 contracts (Direct);
Stock Options (Right to Buy) — 8,160 contracts (Direct);
Common Stock — 13,113 shares (Direct);
Common Stock — 1,740 shares (Indirect, Lin Family Trust Feb 4, 2024)
Footnotes (3)
- F1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
- F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
- F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
Key Figures
RSUs granted: 8450.0000 units
RSU balance after grant: 11389.0000 units
Stock options underlying shares: 8160.0000 shares
+4 more
7 metrics
RSUs granted
8450.0000 units
Restricted Stock Units granted to Patrick Lin on 2026-07-26
RSU balance after grant
11389.0000 units
Total Restricted Stock Units held by Patrick Lin after the award
Stock options underlying shares
8160.0000 shares
Underlying common shares for options held directly by Patrick Lin
Option exercise price
4.9600
Exercise price per share for Patrick Lin’s stock options
Direct common stock holdings
13113.0000 shares
Common stock held directly by Patrick Lin
Indirect common stock holdings
1740.0000 shares
Common stock held indirectly via Lin Family Trust Feb 4, 2024
Reverse stock split ratio
1-for-25
Reverse stock split effective December 17, 2025
Key Terms
Restricted Stock Units, Stock Options (Right to Buy), 1-for-25 reverse stock split, change of control, +1 more
5 terms
Restricted Stock Units financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with an exercise price of 4.9600"
1-for-25 reverse stock split financial
"Reflects the 1-for-25 reverse stock split effected by the Issuer"
change of control financial
"distributed until the earlier of termination, six months, change of control, or death"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Rule 10b5-1 trading plan financial
"Transactions were not reported as made under a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Processa Pharmaceuticals (PCSA) report about Patrick Lin’s new equity award?
Patrick Lin received 8,450 Restricted Stock Units (RSUs) on 2026-07-26. Each RSU equals one share of common stock, vests immediately upon grant, and will be distributed only upon termination, six months after grant, a change of control, or death.
How do the new RSUs for Processa (PCSA) executive Patrick Lin vest and pay out?
The 8,450 RSUs granted to Patrick Lin vested upon grant but defer distribution. Shares will be delivered at the earlier of termination, six months after the grant date, a change of control, or his death, according to the award terms.
What stock option position does Patrick Lin hold at Processa Pharmaceuticals (PCSA)?
Patrick Lin holds stock options over 8,160 underlying common shares at an exercise price of $4.9600. These options vest one-third on the first anniversary of the grant date, with the remaining two-thirds vesting ratably over the following two years.
How did Processa’s 1-for-25 reverse stock split affect Patrick Lin’s reported holdings in PCSA?
All reported equity numbers, including 11,389 RSUs and options over 8,160 shares, reflect a 1-for-25 reverse stock split that was effective on December 17, 2025. The split adjusted prior share and unit counts proportionally.
Were Patrick Lin’s reported PCSA equity transactions made under a Rule 10b5-1 plan?
The filing indicates the transactions were not made under a Rule 10b5-1 trading plan. The document-level checkbox for Rule 10b5-1 arrangements is explicitly unchecked, suggesting no pre-arranged trading plan covered these reported equity awards and holdings.
AI-generated analysis. How Rhea-AI works. Not financial advice.
